A large cohort study found no significant association between migraines, their subtypes, or frequency and Parkinson disease (PD) risk in women 45 years and older, suggesting migraines may not contribute to...
A new randomized clinical trial found that psilocybin therapy reduced symptoms of depression in frontline clinicians affected by the COVID-19 pandemic, with effects lasting up to 6 months.
In an interview with Consultant360, Kasia Rothenberg, MD, PhD, a geriatric psychiatrist at the Cleveland Clinic Lou Ruvo Center for Brain Health, described the challenges caregivers or family members face...
In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
In a 2024 review, the International Psychogeriatric Association introduces a systematic method to manage agitation in patients with Alzheimer disease. Take our quiz to test your knowledge on this...
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
In this video, Gautam Dantas, PhD, discusses the results of his study, which showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease. He also talks about whether...
In this video, Paul B. Rosenberg, MD, discusses his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. The study found that dronabinol...
Jeff Cummings, MD, ScD; Carolyn Clevenger, DNP, RN, GNP-BC, FAANP, FGSA, FAAN; Tatyana Gurvich, PharmD, BCGP; Lakelyn Hogan Eichenberger, PhD, MA, MBA; W. Clay Jackson, MD, DipTh; Sean Tunis, MD, MSc; Kate Zhong, MD, MSc, FRCP
Agitation in Alzheimer’s dementia is a serious neuropsychiatric condition that is highly prevalent and underdiagnosed. It contributes to adverse clinical outcomes for people living with Alzheimer’s dementia...
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
